Natco Pharma Ltd

NATCOPHARM

Company Profile

  • Business description

    Natco Pharma Ltd is a drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. It derives maximum revenue from Pharmaceuticals Segment.

  • Contact

    Road No. 2, NATCO House
    Banjara Hills
    HyderabadTG500034
    IND

    T: +91 4023547532

    https://www.natcopharma.co.in

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    4,762

Stocks News & Analysis

stocks

WiseTech result disappoints, but the future looks bright

Markets appear underwhelmed by recent sales growth, however, our kingmaker thesis is intact.
stocks

WOW earnings: Woolworths losing market share, but will catch up to Coles

Woolworths have had a soft start to a challenging year, but Morningstar analyst believes it will eventually catch up to its main competitor.
stocks

Chart of the Week: Largest share price falls during earnings

Opportunities arise when the market overreacts, and good quality companies are mispriced.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,241.100.50-0.01%
CAC 407,762.6018.670.24%
DAX 4024,039.926.29-0.03%
Dow JONES (US)45,573.147.910.02%
FTSE 1009,216.8238.68-0.42%
HKSE24,998.82202.94-0.81%
NASDAQ21,700.56110.420.51%
Nikkei 22542,828.79308.520.73%
NZX 50 Index12,903.0841.240.32%
S&P 5006,495.7614.360.22%
S&P/ASX 2008,980.009.500.11%
SSE Composite Index3,843.6043.251.14%

Market Movers